SCI Pharmtech, Inc. — Investor Relations & Filings
SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 114年度毛利率 | 2026-03-05 | Chinese | |
| 114年度股利金額(董事會決議) | 2026-03-05 | Chinese | |
| 公告本公司114年財務合併報告提報董事會。 | 2026-03-05 | Chinese | |
| 公告本公司114年財務合併報告董事會預計召開日期 為115年3月5日。 | 2026-02-25 | Chinese | |
| 115年1月背書保證與資金貸與 | 2026-02-09 | Chinese | |
| 115年1月營業收入 | 2026-02-09 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 34537452 | 114年度毛利率 | 2026-03-05 | Chinese | ||
| 34537463 | 114年度股利金額(董事會決議) | 2026-03-05 | Chinese | ||
| 34537465 | 公告本公司114年財務合併報告提報董事會。 | 2026-03-05 | Chinese | ||
| 34537467 | 公告本公司114年財務合併報告董事會預計召開日期 為115年3月5日。 | 2026-02-25 | Chinese | ||
| 34537470 | 115年1月背書保證與資金貸與 | 2026-02-09 | Chinese | ||
| 34537468 | 115年1月營業收入 | 2026-02-09 | Chinese | ||
| 34537473 | 115年01月內部人持股異動(事後) | 2026-02-06 | Chinese | ||
| 34537471 | 115年01月董事會成員及持股 | 2026-02-06 | Chinese | ||
| 34537477 | 114年12月營業收入 | 2026-01-08 | Chinese | ||
| 34537474 | 114年12月背書保證與資金貸與 | 2026-01-08 | Chinese | ||
| 34537479 | 114年12月董事會成員及持股 | 2026-01-07 | Chinese | ||
| 34537478 | 114年12月內部人持股異動(事後) | 2026-01-07 | Chinese | ||
| 34537481 | 功能性委員會成員 | 2026-01-05 | Chinese | ||
|
2025
2 filings
| |||||
| 34539533 | 114年第3季財務報告書 — 202504_4119_AI3.pdf | 2025-12-18 | Chinese | ||
| 34539525 | 114年第3季財務報告書 — 202504_4119_AI1.pdf | 2025-12-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SCI Pharmtech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52383/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52383 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52383 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52383 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52383}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SCI Pharmtech, Inc. (id: 52383)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.